Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Jun 5, 2025, 4:00 PM
1.650
-0.010 (-0.60%)
After-hours: Jun 5, 2025, 4:35 PM EDT

Metagenomi Statistics

Total Valuation

Metagenomi has a market cap or net worth of $62.05 million. The enterprise value is -$119.48 million.

Market Cap 62.05M
Enterprise Value -119.48M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

Metagenomi has 37.38 million shares outstanding. The number of shares has increased by 372.04% in one year.

Current Share Class 37.38M
Shares Outstanding 37.38M
Shares Change (YoY) +372.04%
Shares Change (QoQ) -0.77%
Owned by Insiders (%) 11.03%
Owned by Institutions (%) 24.93%
Float 23.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.39
Forward PS 2.98
PB Ratio 0.30
P/TBV Ratio 0.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.21.

Current Ratio 5.85
Quick Ratio 5.73
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -31.93% and return on invested capital (ROIC) is -18.87%.

Return on Equity (ROE) -31.93%
Return on Assets (ROA) -15.37%
Return on Invested Capital (ROIC) -18.87%
Return on Capital Employed (ROCE) -33.99%
Revenue Per Employee $224,074
Profits Per Employee -$385,886
Employee Count 202
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax -5.42M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.86% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -73.86%
50-Day Moving Average 1.58
200-Day Moving Average 2.27
Relative Strength Index (RSI) 53.47
Average Volume (20 Days) 296,929

Short Selling Information

The latest short interest is 2.40 million, so 6.43% of the outstanding shares have been sold short.

Short Interest 2.40M
Short Previous Month 2.96M
Short % of Shares Out 6.43%
Short % of Float 10.32%
Short Ratio (days to cover) 6.61

Income Statement

In the last 12 months, Metagenomi had revenue of $45.26 million and -$77.95 million in losses. Loss per share was -$2.11.

Revenue 45.26M
Gross Profit -57.62M
Operating Income -87.69M
Pretax Income n/a
Net Income -77.95M
EBITDA -82.20M
EBIT -87.69M
Loss Per Share -$2.11
Full Income Statement

Balance Sheet

The company has $225.97 million in cash and $44.44 million in debt, giving a net cash position of $181.53 million or $4.86 per share.

Cash & Cash Equivalents 225.97M
Total Debt 44.44M
Net Cash 181.53M
Net Cash Per Share $4.86
Equity (Book Value) 212.66M
Book Value Per Share 5.69
Working Capital 193.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$102.07 million and capital expenditures -$2.49 million, giving a free cash flow of -$104.55 million.

Operating Cash Flow -102.07M
Capital Expenditures -2.49M
Free Cash Flow -104.55M
FCF Per Share -$2.80
Full Cash Flow Statement

Margins

Gross margin is -127.30%, with operating and profit margins of -193.73% and -172.21%.

Gross Margin -127.30%
Operating Margin -193.73%
Pretax Margin -184.18%
Profit Margin -172.21%
EBITDA Margin -181.60%
EBIT Margin -193.73%
FCF Margin n/a

Dividends & Yields

Metagenomi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -372.04%
Shareholder Yield -372.04%
Earnings Yield -125.62%
FCF Yield -168.49%

Analyst Forecast

The average price target for Metagenomi is $13.00, which is 683.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.00
Price Target Difference 683.13%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Metagenomi has an Altman Z-Score of -0.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.21
Piotroski F-Score 1